Targeting Bortezomib to Bone Increases its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice

This article is protected by copyright. All rights reserved.

Source: Journal of Bone and Mineral Research - October 13, 2019 Category: Orthopaedics Authors: Hua Wang, Hengwei Zhang, Venkat Srinivasan, Jianguo Tao, Wen Sun, Xi Lin, Tao Wu, Brendan F. Boyce, Frank H. Ebetino, Robert K. Boeckman, Lianping Xing Tags: Original Article Source Type: research